Premium
Inhibition of Ca 2+ channel surface expression by mutant bestrophin‐1 in RPE cells
Author(s) -
Cordes Magdalena,
Bucichowski Piotr,
Alfaar Ahmad S.,
Tsang Stephen H.,
Almedawar Seba,
Reichhart Nadine,
Strauß Olaf
Publication year - 2020
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.201901202rr
Subject(s) - mutant , retinal pigment epithelium , microbiology and biotechnology , chemistry , transfection , cav1.2 , hek 293 cells , retinal , intracellular , biology , biochemistry , gene , protein subunit
The BEST1 gene product bestrophin‐1, a Ca 2+ ‐dependent anion channel, interacts with Ca V 1.3 Ca 2+ channels in the retinal pigment epithelium (RPE). BEST1 mutations lead to Best vitelliform macular dystrophy. A common functional defect of these mutations is reduced trafficking of bestrophin‐1 into the plasma membrane. We hypothesized that this defect affects the interaction partner Ca V 1.3 channel affecting Ca 2+ signaling and altered RPE function. Thus, we investigated the protein interaction between Ca V 1.3 channels and bestrophin‐1 by immunoprecipitation, Ca V 1.3 activity in the presence of mutant bestrophin‐1 and intracellular trafficking of the interaction partners in confluent RPE monolayers. We selected four BEST1 mutations, each representing one mutational hotspot of the disease: T6P, F80L, R218C, and F305S. Heterologously expressed L‐type channels and mutant bestrophin‐1 showed reduced interaction, reduced Ca V 1.3 channel activity, and changes in surface expression. Transfection of polarized RPE (porcine primary cells, iPSC‐RPE) that endogenously express Ca V 1.3 and wild‐type bestrophin‐1, with mutant bestrophin‐1 confirmed reduction of Ca V 1.3 surface expression. For the four selected BEST1 mutations, presence of mutant bestrophin‐1 led to reduced Ca V 1.3 activity by modulating pore‐function or decreasing surface expression. Reduced Ca V 1.3 activity might open new ways to understand symptoms of Best vitelliform macular dystrophy such as reduced electro‐oculogram, lipofuscin accumulation, and vision impairment.